CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-29 | Moat Ross CHIEF COMMERCIAL OFFICER | Option exercise · Share Option 10b5-1 | −15,000 | 0 | ||
| 2025-04-29 | Moat Ross CHIEF COMMERCIAL OFFICER | Option exercise · Share Option 10b5-1 | −20,000 | 0 | ||
| 2025-04-29 | Moat Ross CHIEF COMMERCIAL OFFICER | Option exercise · Share Option 10b5-1 | −6,296 | 1,658 | ||
| 2025-04-29 | Moat Ross CHIEF COMMERCIAL OFFICER | Option exercise · Share Option 10b5-1 | −7,432 | 27,252 | ||
| 2025-04-29 | Moat Ross CHIEF COMMERCIAL OFFICER | Option exercise · Share Option 10b5-1 | −15,307 | 23,361 | ||
| 2025-04-29 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +20,000 | $15.52 | $310K | 47,009 |
| 2025-04-29 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +22,000 | $15.50 | $341K | 69,009 |
| 2025-04-29 | Ragosa Mark CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −42,000 | $25.61 | $1.1M | 27,009 |
| 2025-04-29 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise · Share Option 10b5-1 | −20,000 | 0 | ||
| 2025-04-29 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise · Share Option 10b5-1 | −22,000 | 0 | ||
| 2025-04-26 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise | +990 | 27,488 | ||
| 2025-04-26 | Ragosa Mark CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −479 | $21.37 | $10K | 27,009 |
| 2025-04-26 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise · Restricted Share Unit | −990 | 0 | ||
| 2025-04-21 | Moat Ross CHIEF COMMERCIAL OFFICER | Sale 10b5-1 | −18,259 | $20.29 | $370K | 9,415 |
| 2025-04-14 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +7,000 | $3.80 | $27K | 89,363 |
| 2025-04-14 | Tessari Eben CHIEF OPERATING OFFICER | Sale 10b5-1 | −5,579 | $20.19 | $113K | 83,784 |
| 2025-04-14 | Tessari Eben CHIEF OPERATING OFFICER | Sale 10b5-1 | −6,421 | $20.74 | $133K | 77,363 |
| 2025-04-14 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise · Share Option 10b5-1 | −7,000 | 7,049 | ||
| 2025-04-07 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise | +2,726 | 83,164 | ||
| 2025-04-07 | Tessari Eben CHIEF OPERATING OFFICER | Shares withheld for taxes | −801 | $20.28 | $16K | 82,363 |
Page 37 of 74 · 1,467 trades